Perrigo Company plc Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Perrigo Company plc (PRGO) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 0 shares for the 3-month period ending 2023-04-01, per its 10-Q filed 2023-05-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2023-05-09
- Perrigo Company plc antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-04-01 was 0.00 shares.
- Perrigo Company plc antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2022-10-01 was 0.00 shares.
- Perrigo Company plc antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2022-07-02 was 0.00 shares.
- Perrigo Company plc antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2022-04-02 was 0.00 shares, a 100.00% decline year-over-year.
- Perrigo Company plc antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 0.00 shares.
- Perrigo Company plc antidilutive securities excluded from computation of earnings per share, amount for fiscal 2020 was 0.00 shares, a 100.00% decline from fiscal 2019.
- Perrigo Company plc antidilutive securities excluded from computation of earnings per share, amount for fiscal 2019 was 1.50M shares, a 7.14% increase from fiscal 2018.
- Perrigo Company plc antidilutive securities excluded from computation of earnings per share, amount for fiscal 2018 was 1.40M shares, a 75.00% increase from fiscal 2017.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|
| 2023-04-01 | 0.00 shares 10-Q · filed 2023-05-09 | |||||
| 2022-10-01 | 0.00 shares 10-Q · filed 2022-11-08 | 0.00 shares 10-Q · filed 2022-11-08 | ||||
| 2022-07-02 | 0.00 shares 10-Q · filed 2022-08-09 | 0.00 shares 10-Q · filed 2022-08-09 | ||||
| 2022-04-02 | 0.00 shares 10-Q · filed 2023-05-09 | |||||
| 2021-12-31 | 0.00 shares 10-K · filed 2022-03-01 | |||||
| 2021-10-02 | 0.00 shares 10-Q · filed 2022-11-08 | 0.00 shares 10-Q · filed 2022-11-08 | ||||
| 2021-07-03 | 0.00 shares 10-Q · filed 2022-08-09 | 0.00 shares 10-Q · filed 2022-08-09 | ||||
| 2021-04-03 | 1.80M shares 10-Q · filed 2022-05-11 | |||||
| 2020-12-31 | 0.00 shares 10-K · filed 2022-03-01 | |||||
| 2020-09-26 | 1.50M shares 10-Q · filed 2021-11-12 | 0.00 shares 10-Q · filed 2020-11-05 | 1.50M shares 10-Q · filed 2021-11-12 | |||
| 2020-06-27 | 1.50M shares 10-Q · filed 2021-08-11 | 1.50M shares 10-Q · filed 2021-08-11 | ||||
| 2020-03-28 | 1.70M shares 10-Q · filed 2021-05-12 | |||||
| 2019-12-31 | 1.50M shares 10-K · filed 2022-03-01 | |||||
| 2019-09-28 | 1.50M shares 10-Q · filed 2020-11-05 | 1.80M shares 10-Q · filed 2020-11-05 | ||||
| 2019-06-29 | 1.70M shares 10-Q · filed 2020-08-05 | 1.80M shares 10-Q · filed 2020-08-05 | ||||
| 2019-03-30 | 2.10M shares 10-Q · filed 2020-05-05 | |||||
| 2018-12-31 | 1.40M shares 10-K · filed 2021-03-01 | |||||
| 2018-09-29 | 0.00 shares 10-Q · filed 2019-11-06 | 1.20M shares 10-Q · filed 2019-11-06 | ||||
| 2018-06-30 | 1.70M shares 10-Q · filed 2019-08-08 | 900.00K shares 10-Q · filed 2019-08-08 | ||||
| 2018-03-31 | 700.00K shares 10-Q · filed 2019-05-09 | |||||
| 2017-12-31 | 800.00K shares 10-K · filed 2020-02-27 | |||||
| 2017-09-30 | 1.00M shares 10-Q · filed 2018-11-08 | 800.00K shares 10-Q · filed 2018-11-08 | ||||
| 2017-07-01 | 0.00 shares 10-Q · filed 2018-08-09 | 800.00K shares 10-Q · filed 2018-08-09 | ||||
| 2017-04-01 | 1.00M shares 10-Q · filed 2018-05-08 | |||||
| 2016-12-31 | 0.00 shares 10-K · filed 2019-02-27 | |||||
| 2016-10-01 | 0.00 shares 10-Q · filed 2017-11-09 | 0.00 shares 10-Q · filed 2017-11-09 | ||||
| 2016-07-02 | 0.00 shares 10-Q · filed 2017-08-10 | 1.00M shares 10-Q · filed 2016-08-10 | 0.00 shares 10-Q · filed 2017-08-10 | |||
| 2016-04-02 | 0.00 shares 10-Q · filed 2017-05-30 | 300.00K shares 10-Q · filed 2016-05-16 | ||||
| 2015-12-31 | 100.00K shares 10-K · filed 2018-03-01 | 0.00 shares 10-KT · filed 2016-02-25 | ||||
| 2015-09-26 | 100.00K shares 10-Q/A · filed 2017-05-23 | 0.00 shares 10-Q/A · filed 2017-05-23 | ||||
| 2015-06-27 | 0.00 shares 10-Q/A · filed 2017-05-22 | 0.00 shares 10-Q/A · filed 2017-05-22 | 100.00K shares 10-K · filed 2018-03-01 | |||
| 2015-03-28 | 0.00 shares 10-Q/A · filed 2017-05-22 | 700.00K shares 10-Q · filed 2015-04-29 | 100.00K shares 10-Q · filed 2015-04-29 | |||
| 2014-12-27 | 200.00K shares 10-Q · filed 2015-02-05 | 100.00K shares 10-Q · filed 2015-02-05 | ||||
| 2014-09-27 | 0.00 shares 10-Q · filed 2015-11-02 | 100.00K shares 10-Q · filed 2014-11-06 | ||||
| 2014-06-28 | 100.00K shares 10-K · filed 2017-05-22 | |||||
| 2014-03-29 | 0.00 shares 10-Q · filed 2015-04-29 | 100.00K shares 10-Q · filed 2015-04-29 | ||||
| 2013-12-28 | 200.00K shares 10-Q · filed 2015-02-05 | 100.00K shares 10-Q · filed 2015-02-05 | ||||
| 2013-09-28 | 100.00K shares 8-K · filed 2014-11-20 | |||||
| 2013-06-29 | 200.00K shares 10-KT · filed 2016-02-25 | |||||
| 2013-03-30 | 200.00K shares 10-Q · filed 2014-05-07 | 200.00K shares 10-Q · filed 2014-05-07 | ||||
| 2012-12-29 | 200.00K shares 10-Q · filed 2014-02-06 | 100.00K shares 10-Q · filed 2014-02-06 | ||||
| 2012-06-30 | 200.00K shares 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |